---
$id: https://graph.org.ai/products/commodity/51201814
$type: Product
source: UNSPSC
code: "51201814"
title: "Bropirimine"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bropirimine

**UNSPSC Code**: 51201814
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunostimulant with the molecular formula C10H8BrN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J57CTF25XJ, chemically known as 4-pyrimidinol, 2-amino-5-bromo-6-phenyl- but generally known as bropirimine, which bears US NIH Compound Identifier 65457. European Medicines Agency schedules Bropirimine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05928MIG. The term BROPIRIMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). BROPIRIMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bropirimine under HS 29335995 and SITC 51576. As of Q4 2014, BROPIRIMINE remains the US FDA Preferred Term for this commodity. Bropirimine bears US NLM identifiers UMLS ID C0054150 and NCI Concept Code C1024. SMILES: C1=CC=C(C=C1)C2=C(C(=O)N=C(N2)N)BR.

